HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration
- 1 February 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (2) , 614-624
- https://doi.org/10.1046/j.1523-1755.2001.059002614.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Coexpression of CD9 augments the ability of membrane-bound heparin-binding epidermal growth factor-like growth factor (proHB-EGF) to preserve renal epithelial cell viabilityKidney International, 1999
- Response of the human peritoneal mesothelial cell to injury: An in vitro model of peritoneal wound healingKidney International, 1998
- High glucose and hyperosmolarity increase heparin‐binding epidermal growth factor‐like growth factor (HB‐EGF) production in cultured human aortic endothelial cellsCell Biochemistry and Function, 1996
- Alteration of Integrins by Heparin-Binding EGF Like Growth Factor in Human Breast Cancer CellsOncology, 1996
- Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.The Journal of cell biology, 1995
- Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin.The Journal of cell biology, 1993
- Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursorCell, 1992
- Growth factors and cutaneous wound repairProgress in Growth Factor Research, 1992
- Activation of immunocompetent cells in the peritoneum of patients treated with CAPDKidney International, 1989
- Peritoneal Morphology on Maintenance DialysisAmerican Journal of Nephrology, 1989